MGH has been at the forefront of many scientific advances in treatments for depression.
As Director Emeritus of the DCRP, Dr. Maurizio Fava founded the DCRP in 1990 and was director from 1990 to 2014. He is currently director of the Clinical Research Program (CRP) at MGH, executive vice chair of psychiatry at MGH, executive director of the MGH Clinical Trials Network and Institute (CTNI), and the Slater Family Professor of Psychiatry at Harvard Medical School. He was the co-principal investigator of the STAR*D trial with Dr. A. John Rush, the largest clinical trial ever conducted in depression. In addition to his numerous clinical trials and studies in treatment-resistant depression, Dr. Fava has contributed significantly to the field of psychiatric research in a number of other areas. He is currently the principal investigator of the NIMH-sponsored RAPID contract, studying novel treatments for depression with rapid antidepressant effects through a network of academic sites. Over the past 24 years, Dr. Fava has trained and mentored more than 50 research fellows and junior faculty in his program, many of whom have continued to work in the area of psychiatric research following completion of their fellowship. Dr. Fava is considered an expert psychopharmacologist in the area of depression and frequently provides consultations to difficult cases referred to him from all over the world. He has published more than 600 original articles in the literature and has an h factor greater than 100. View Dr. Fava’s research: http://www.ncbi.nlm.nih.gov/pubmed/?term=Fava+M+%5BAuthor%5D